|Articles|March 1, 2019
- BioPharm International-03-01-2019
- Volume 32
- Issue 3
BioPharm International, March 2019 Issue (PDF)
Click the title above to open the BioPharm International March 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Regulatory Considerations Associated with Alternative Dosage Formsalmost 7 years ago
Successfully Moving Regulated Data to the Cloudalmost 7 years ago
Strategic Ventures Reflect Dynamic Growth in Chinaalmost 7 years ago
CMOs Leading the Way on Single-Use Systems Adoptionalmost 7 years ago
Cell and Gene Therapies Gain Streamlined FDA Oversightalmost 7 years ago
Considering Alternative Dosage Forms in Biologicsalmost 7 years ago
Test Methods and Quality Control for Prefilled Syringesalmost 7 years ago
Is Simplification Aiding Data Integrity Compliance?almost 7 years ago
Caught in a Conundrumalmost 7 years ago
Process Validation Sets the Stage for Ongoing Manufacturing QualityNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
3
Developing Next-Gen Cell Lines Using Targeted Integration
4
FAQ: Shifts in FDA Regulations and Strategies in 2025
5
